Oncology novel active substance (NAS) launches (cumulative) vs Novel active substance launches
Oncology novel active substance (NAS) launches (cumulative) and Novel active substance launches worldwide, compared over time.
Change the pair
Compare different indicators
The series
Over time
Global, spaced by time. Both series are in count, so they share one axis; the legend names each line.
Oncology novel active substance (NAS) launches (cumulative) and Novel active substance launches
Unit: count · 5 observations
View the underlying data
| Indicator | Period | Type | Value |
|---|---|---|---|
| Oncology novel active substance (NAS) launches (cumulative) | 2020–2024 | Actual | 132 |
| Oncology novel active substance (NAS) launches (cumulative) | 2015–2019 | Actual | 79 |
| Oncology novel active substance (NAS) launches (cumulative) | 2005–2024 | Actual | 282 |
| Novel active substance launches | 2025 | Actual | 79 |
| Novel active substance launches | 2004–2023 | Actual | 942 |
Source: IQVIA, IFPMA · CC BY 4.0 · Oncology novel active substance (NAS) launches (cumulative) · Novel active substance launches
Provenance
Where these numbers come from
Oncology novel active substance (NAS) launches (cumulative)
Total number of oncology novel active substances launched over a stated multi-year period.
3 observations in Global · source organisations: IQVIA
Novel active substance launches
Total number of novel active substances launched.
2 observations in Global · source organisations: IFPMA, IQVIA
Data published under CC BY 4.0. Series A as JSON · Series B as JSON
Keep exploring